#D9TS_Picks #IREN — IREN is expanding its AI cloud business through major customer contracts and data-center capacity growth. FY2026 revenue rose 41% YoY to $707M, AI Cloud revenue climbed nearly 8× to $128.8M, and the company reported $4B in contracted ARR for 2026 capacity Resistance: $31.70, $33.01 | Support: $27.84 For Detailed analysis 👉 https://t.me/c/2454754655/4545 #APPN — Appian is benefiting from enterprise demand for low-code software and AI-powered process automation. Q1 FY2026 revenue reached $202.2M, up 21.5% YoY, while cloud subscription revenue grew 25%, supporting its enterprise digital-transformation opportunity. Resistance: $44.05, $46.00 | Support: $40.50 For Detailed analysis 👉 https://t.me/c/2454754655/9368 #ZURA — Zura Bio is approaching key clinical catalysts for its investigational antibody, tibulizumab, targeting autoimmune and inflammatory diseases. Phase 2 enrollment is complete in both HS (247 participants) and systemic sclerosis (91 participants), with HS topline data expected in Q4 2026 and $205.1M in cash reported as of June 30, 2026. Resistance: $4.50, $4.80 | Support: $3.85 For Detailed analysis 👉https://t.me/c/2454754655/10438 👉 Join our ThinkSabio Stocks WL999 Group To join, simply visit our ThinkSabio Community Page or access the ThinkSabio Bot